QR Kodea

Validation study of the antineutrophil cytoplasmic antibody (ANCA) kidney risk score in Japanese patients with ANCA-associated glomerulonephritis

In 2018, the Antineutrophil Cytoplasmic Antibody (ANCA) Renal Risk Score (ARRS) was proposed as a prognostic tool for renal outcomes in patients with ANCA-associated glomerulonephritis (AAGN). Subsequently, a revised version of the ANCA Kidney Risk Score (AKRiS) was reported in 2024. Nonetheless, it...

Deskribapen osoa

Gorde:
Egile Nagusiak: Ayuko Yamashita, Mineaki Kitamura, Kumiko Muta, Mayu Iwata, Emiko Otsuka, Kenta Torigoe, Tomohisa Uchida, Kunihiro Ichinose, Takahiro Takazono, Noriho Sakamoto, Atsushi Kawakami, Hiroshi Mukae, Tomoya Nishino
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis Group 2026-12-01
Saila:Renal Failure
Gaiak:
ANCA associated glomerulonephritis
ANCA kidney risk score
validation study
end stage kidney disease
risk
Sarrera elektronikoa:https://www.tandfonline.com/doi/10.1080/0886022X.2026.2678630
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak